true 2022 Q1 0001615165 --12-31 P2Y P4Y P5Y P5Y P5Y P1Y P5Y P1Y P5Y P10Y P5Y P5Y P4Y P5Y P7Y P0Y P0Y P3Y1M6D P5Y10M24D P3M18D P4Y7M6D P5Y4M24D P6Y1M6D 0.88 P6M P2Y 0.71 0.002 0.024 P6Y3M18D P6Y3M18D P6Y2M12D P5Y4M24D 0001615165 2022-01-01 2022-03-31 xbrli:shares 0001615165 2022-04-30 iso4217:USD 0001615165 2022-03-31 0001615165 2021-12-31 iso4217:USD xbrli:shares 0001615165 2021-01-01 2021-03-31 0001615165 us-gaap:CommonStockMember 2021-12-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001615165 us-gaap:RetainedEarningsMember 2021-12-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001615165 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001615165 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001615165 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001615165 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001615165 us-gaap:CommonStockMember 2022-03-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001615165 us-gaap:RetainedEarningsMember 2022-03-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001615165 us-gaap:CommonStockMember 2020-12-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001615165 us-gaap:RetainedEarningsMember 2020-12-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001615165 2020-12-31 0001615165 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001615165 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001615165 us-gaap:CommonStockMember 2021-03-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001615165 us-gaap:RetainedEarningsMember 2021-03-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001615165 2021-03-31 0001615165 veri:March2022AcquisitionMember 2022-01-01 2022-03-31 0001615165 veri:PandologicsLtdMember 2022-01-01 2022-03-31 0001615165 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001615165 us-gaap:EmployeeStockMember 2022-01-01 2022-03-31 0001615165 us-gaap:PerformanceSharesMember 2022-01-01 2022-03-31 0001615165 srt:ScenarioPreviouslyReportedMember 2022-03-31 0001615165 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-03-31 0001615165 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-03-31 0001615165 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-01-01 2022-03-31 0001615165 us-gaap:RetainedEarningsMember srt:ScenarioPreviouslyReportedMember 2021-12-31 0001615165 us-gaap:RetainedEarningsMember srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-12-31 0001615165 us-gaap:RetainedEarningsMember srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-03-31 0001615165 us-gaap:RetainedEarningsMember srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-01-01 2022-03-31 0001615165 us-gaap:RetainedEarningsMember srt:ScenarioPreviouslyReportedMember 2022-03-31 0001615165 us-gaap:RetainedEarningsMember srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-03-31 0001615165 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001615165 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-12-31 0001615165 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001615165 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-01-01 2021-12-31 0001615165 2021-01-01 2021-12-31 0001615165 us-gaap:RetainedEarningsMember srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001615165 us-gaap:RetainedEarningsMember srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-01-01 2021-12-31 0001615165 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001615165 2020-01-01 2020-12-31 0001615165 veri:PandologicLtdMember 2022-01-01 2022-03-31 veri:Customer 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 xbrli:pure 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2022-01-01 2022-03-31 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2021-01-01 2021-03-31 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember 2021-01-01 2021-12-31 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember srt:MinimumMember 2021-01-01 2021-03-31 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember srt:MinimumMember 2021-01-01 2021-12-31 0001615165 2022-04-01 2022-03-31 0001615165 veri:PurchaseAgreementMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:PurchaseAgreementMember veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:PurchaseAgreementMember us-gaap:CommonStockMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:PurchaseAgreementMember srt:MaximumMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:March2022AcquisitionMember srt:MinimumMember 2022-03-01 2022-03-01 0001615165 veri:March2022AcquisitionMember srt:MaximumMember 2022-03-01 2022-03-01 0001615165 veri:InfluencerNetworkMember veri:March2022AcquisitionMember 2022-03-01 0001615165 us-gaap:TradeNamesMember veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:BrandRelationshipsMember veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:InfluencerNetworkMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 us-gaap:TradeNamesMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:BrandRelationshipsMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:PandologicsLtdMember veri:MergerAgreementMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:MergerAgreementMember 2021-09-14 0001615165 veri:PandologicsLtdMember veri:MergerAgreementMember us-gaap:CommonStockMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:MergerAgreementMember srt:MaximumMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:ContingentConsiderationsMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:RecognizedInCompensationExpenseWithinGeneralAndAdministrativeExpenseMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001615165 veri:PandologicLtdMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember veri:ContingentConsiderationMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember 2021-09-14 0001615165 veri:PandologicLtdMember srt:MinimumMember 2022-01-01 2022-03-31 0001615165 veri:PandologicLtdMember srt:MaximumMember 2022-01-01 2022-03-31 0001615165 veri:PandologicLtdMember us-gaap:CustomerRelationshipsMember 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:DevelopedTechnologyRightsMember 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:TradeNamesMember 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:CustomerRelationshipsMember srt:MinimumMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:CustomerRelationshipsMember srt:MaximumMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:DevelopedTechnologyRightsMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:TradeNamesMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember 2022-03-31 0001615165 veri:PandologicLtdMember country:IL 2022-01-01 2022-03-31 0001615165 veri:PandologicLtdMember country:IL 2021-09-14 2021-09-14 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2021-11-30 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2022-03-31 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2022-01-01 2022-03-31 veri:Day 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2021-11-01 2021-11-30 0001615165 2021-11-01 2021-11-30 iso4217:USD veri:Derivative 0001615165 2021-11-16 0001615165 veri:EmployeeStockOptionAndRestrictedStockUnitsMember 2022-01-01 2022-03-31 0001615165 veri:EmployeeStockOptionAndRestrictedStockUnitsMember 2021-01-01 2021-03-31 0001615165 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001615165 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001615165 veri:CommonStockIssuableInConnectionWithConvertibleSeniorNotesMember 2022-01-01 2022-03-31 0001615165 us-gaap:CashMember 2022-03-31 0001615165 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2022-03-31 0001615165 us-gaap:CashMember 2021-12-31 0001615165 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-12-31 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityCurrentMember 2022-03-31 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityNoncurrentMember 2022-03-31 0001615165 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityCurrentMember 2021-12-31 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityNoncurrentMember 2021-12-31 0001615165 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001615165 us-gaap:OtherNoncurrentAssetsMember 2022-03-31 0001615165 veri:SoftwareAndTechnologyMember 2022-01-01 2022-03-31 0001615165 veri:LicensedTechnologyMember 2022-01-01 2022-03-31 0001615165 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-03-31 0001615165 veri:CustomerAndSupplierRelationshipsMember 2022-01-01 2022-03-31 0001615165 us-gaap:NoncompeteAgreementsMember 2022-01-01 2022-03-31 0001615165 us-gaap:TradeNamesMember 2022-01-01 2022-03-31 0001615165 veri:SoftwareAndTechnologyMember 2022-03-31 0001615165 veri:LicensedTechnologyMember 2022-03-31 0001615165 us-gaap:DevelopedTechnologyRightsMember 2022-03-31 0001615165 veri:CustomerAndSupplierRelationshipsMember 2022-03-31 0001615165 us-gaap:NoncompeteAgreementsMember 2022-03-31 0001615165 us-gaap:TradeNamesMember 2022-03-31 0001615165 veri:SoftwareAndTechnologyMember 2021-12-31 0001615165 veri:LicensedTechnologyMember 2021-12-31 0001615165 us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0001615165 veri:CustomerAndSupplierRelationshipsMember 2021-12-31 0001615165 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001615165 us-gaap:TradeNamesMember 2021-12-31 0001615165 veri:AdvertisingCustomersAndContentLicenseesMember 2022-03-31 0001615165 veri:AdvertisingCustomersAndContentLicenseesMember 2021-12-31 0001615165 us-gaap:ManagementServiceMember 2022-03-31 0001615165 us-gaap:ManagementServiceMember 2021-12-31 0001615165 veri:SoftwareProductsAndServicesMember 2022-03-31 0001615165 veri:SoftwareProductsAndServicesMember 2021-12-31 0001615165 us-gaap:ProductAndServiceOtherMember 2022-03-31 0001615165 us-gaap:ProductAndServiceOtherMember 2021-12-31 0001615165 veri:CommercialEnterpriseMember 2022-01-01 2022-03-31 0001615165 veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 veri:GovernmentAndRegulatedEntitiesMember 2022-01-01 2022-03-31 0001615165 veri:GovernmentAndRegulatedEntitiesMember 2021-01-01 2021-03-31 0001615165 veri:SoftwareProductsAndServicesMember veri:CommercialEnterpriseMember 2022-01-01 2022-03-31 0001615165 veri:SoftwareProductsAndServicesMember veri:GovernmentAndRegulatedIndustriesMember 2022-01-01 2022-03-31 0001615165 veri:SoftwareProductsAndServicesMember 2022-01-01 2022-03-31 0001615165 us-gaap:AdvertisingMember veri:CommercialEnterpriseMember 2022-01-01 2022-03-31 0001615165 us-gaap:AdvertisingMember 2022-01-01 2022-03-31 0001615165 us-gaap:LicenseMember veri:CommercialEnterpriseMember 2022-01-01 2022-03-31 0001615165 us-gaap:LicenseMember 2022-01-01 2022-03-31 0001615165 veri:ManagedServicesMember veri:CommercialEnterpriseMember 2022-01-01 2022-03-31 0001615165 veri:ManagedServicesMember 2022-01-01 2022-03-31 0001615165 veri:CommercialEnterpriseMember 2022-01-01 2022-03-31 0001615165 veri:GovernmentAndRegulatedIndustriesMember 2022-01-01 2022-03-31 0001615165 veri:SoftwareProductsServicesConsistsOfAiWARESaaSSolutionsMember 2022-01-01 2022-03-31 0001615165 veri:SoftwareProductsAndServicesMember veri:PandologicLtdMember 2022-01-01 2022-03-31 0001615165 veri:SoftwareProductsAndServicesMember veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 veri:SoftwareProductsAndServicesMember veri:GovernmentAndRegulatedIndustriesMember 2021-01-01 2021-03-31 0001615165 veri:SoftwareProductsAndServicesMember 2021-01-01 2021-03-31 0001615165 us-gaap:AdvertisingMember veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 us-gaap:AdvertisingMember 2021-01-01 2021-03-31 0001615165 us-gaap:LicenseMember veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 us-gaap:LicenseMember 2021-01-01 2021-03-31 0001615165 veri:ManagedServicesMember veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 veri:ManagedServicesMember 2021-01-01 2021-03-31 0001615165 veri:CommercialEnterpriseMember 2021-01-01 2021-03-31 0001615165 veri:GovernmentAndRegulatedIndustriesMember 2021-01-01 2021-03-31 0001615165 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2022-01-01 0001615165 2022-01-01 0001615165 srt:MinimumMember 2022-03-31 0001615165 srt:MaximumMember 2022-03-31 0001615165 srt:MinimumMember us-gaap:OtherAssetsMember 2022-03-31 0001615165 srt:MinimumMember veri:OtherAccruedLiabilitiesMember 2022-03-31 0001615165 us-gaap:OtherNoncurrentLiabilitiesMember 2022-03-31 utr:sqft 0001615165 veri:OfficeSubleaseMember 2021-02-01 2021-02-28 0001615165 veri:OfficeSubleaseMember 2021-01-01 2021-03-31 0001615165 veri:OfficeSubleaseMember 2022-01-01 2022-03-31 0001615165 veri:LeaseArrangementOneMember 2021-12-31 0001615165 veri:CommonStockAndEmployeeStockPurchasePlanMember 2022-01-01 2022-03-31 0001615165 veri:CommonStockAndEmployeeStockPurchasePlanMember 2021-01-01 2021-03-31 0001615165 us-gaap:CommonStockMember veri:MarchTwoThousandTwentyTwoAcquisitionMember 2022-01-01 2022-03-31 0001615165 us-gaap:CommonStockMember veri:PandologicLtdMember 2022-01-01 2022-03-31 0001615165 veri:TimebasedStockOptionMember 2022-01-01 2022-03-31 0001615165 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001615165 us-gaap:EmployeeStockMember srt:MinimumMember 2022-01-01 2022-03-31 0001615165 us-gaap:EmployeeStockMember srt:MaximumMember 2022-01-01 2022-03-31 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001615165 veri:StockAwardsMember 2021-01-01 2021-03-31 0001615165 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0001615165 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001615165 us-gaap:EmployeeStockMember 2021-01-01 2021-03-31 0001615165 veri:CommonStockIssuedForServicesMember 2022-01-01 2022-03-31 0001615165 veri:CommonStockIssuedForServicesMember 2021-01-01 2021-03-31 0001615165 veri:CostOfRevenueMember 2022-01-01 2022-03-31 0001615165 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001615165 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0001615165 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0001615165 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001615165 us-gaap:PerformanceSharesMember 2021-12-31 0001615165 us-gaap:PerformanceSharesMember 2022-03-31 0001615165 us-gaap:EmployeeStockOptionMember 2021-12-31 0001615165 us-gaap:EmployeeStockOptionMember 2022-03-31 0001615165 veri:EmployeeStockPurchasePlanMember 2022-01-01 2022-03-31 0001615165 veri:EmployeeStockPurchasePlanMember 2022-03-31

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from       to       

Commission File Number: 001-38093

 

Veritone, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

47-1161641

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

2420 17th St., Office 3002, Denver, CO 80202

(Address of principal executive offices, including zip code)

(888) 507-1737

(Registrant’s telephone number, including area code)

 

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

VERI

 

The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2) of the Exchange Act.  Yes   No

As of April 30, 2022, 36,067,923 shares of the registrant’s common stock were outstanding.

 

 


 

EXPLANATORY NOTE

Veritone, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amended Report”) to restate the Company’s unaudited condensed consolidated financial statements for the period ended March 31, 2022 included in its Quarterly Report for the quarter ended March 31, 2022, that was originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 9, 2022 (the “Original Report”). Unless the context otherwise requires, references in this Amended Report to “the Company,” “Veritone,” “we,” “us” or “our” refer to Veritone, Inc. and its wholly owned subsidiaries.

 

Background

As disclosed in the Company’s Current Reports on Form 8-K, as furnished or filed, as applicable, with the SEC on August 9, 2022 and August 15, 2022, the Company is restating its previously issued unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022. On August 9, 2022, the management of the Company and the Audit Committee of the Company’s Board of Directors, after consideration of the relevant facts and circumstances, concluded that the Company’s unaudited condensed consolidated interim financial statements as of March 31, 2022 and for the quarterly period ended March 31, 2022 included in the Original Report should be restated, and that such financial statements previously filed with the SEC should no longer be relied upon due to an error related to the calculation of fair value of contingent consideration at the time of the acquisition of PandoLogic Ltd. (“PandoLogic”), which led to an understatement of goodwill, intangible assets, and contingent consideration at the time of the acquisition, and an overstatement of subsequent changes to the fair value of contingent consideration, and an understatement of subsequent intangible amortization expense in the Original Report (the “Q1 2022 restatement”).

This Amended Report is presented as of the filing date of the Original Report and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the Q1 2022 restatement and the full year 2021 adjustment as described below. Accordingly, this Amended Report should be read in conjunction with the Company’s filings with the SEC subsequent to the date on which the Company filed the Original Report.

This Amended Report sets forth the Original Report in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Report have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Report, and such forward-looking statements should be read in their historical context.

In connection with the Q1 2022 restatement and the filing of this Amended Report, the Company has also adjusted its consolidated balance sheet as of December 31, 2021 contained in the Original Report in order to correct for an error that the Company determined was not material to the Company’s  previously issued financial statements included in its Annual Report on Form 10-K as further described in Note 2 “Presentation and Summary of Significant Accounting Policies” (the “full year 2021 adjustment”).

 

Items Amended in this Amended Report

The following sections in the Original Report are revised in this Amended Report, solely as a result of, and to reflect, the restatement:

 

 

Part I – Item 1. Financial Information

 

Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Part I – Item 4. Controls and Procedures

 

Part II – Item 1A. Risk Factors

 

Part II – Item 6. Exhibits and Signatures

In accordance with applicable SEC rules, this Amended Report includes an updated signature page and certifications of the Company’s Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15.

 

Refer to Note 2, “Presentation and Summary of Significant Accounting Policies,” of Notes to the Condensed Consolidated Financial Statements of this Amended Report for additional information and for the summary of the accounting impacts of these adjustments to the Company’s condensed consolidated financial statements.

 

The Company has also identified a material weakness in its internal control over financial reporting relating to the appropriate oversight and sufficient review of the work performed by third-party specialists on the Company’s behalf and the coordination of work being performed by more than one specialist. In connection with filing of this Amended Report, the Company has reassessed its disclosure controls and procedures and concluded that they were ineffective as of March 31, 2022. See additional discussion included in Part II Item 1A of this Amended Report.

 

 

 


 

VERITONE, INC.

QUARTERLY REPORT ON FORM 10-Q/A

March 31, 2022

TABLE OF CONTENTS

 

Special Note Regarding Forward-Looking Statements

 

 

PART I.

 

FINANCIAL INFORMATION

 

2

Item 1.

 

Financial Statements (Unaudited)

 

2

 

 

Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021

 

2

 

 

Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended March 31, 2022 and 2021

 

3

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2022 and 2021

 

4

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021

 

5

 

 

Notes to the Condensed Consolidated Financial Statements

 

6

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

26

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

35

Item 4.

 

Controls and Procedures

 

35

PART II.

 

OTHER INFORMATION

 

37

Item 1.

 

Legal Proceedings

 

37

Item 1A.

 

Risk Factors

 

37

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

38

Item 3.

 

Defaults Upon Senior Securities

 

38

Item 4.

 

Mine Safety Disclosures

 

38

Item 5.

 

Other Information

 

38

Item 6.

 

Exhibits

 

39

Signatures

 

40

 

 

 


 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q/A contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements made in this Quarterly Report on Form 10-Q/A that are not historical or current facts may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “anticipates,” “believes,” “seeks,” “estimates,” “expects,” “intends,” “continue,” “can,” “may,” “plans,” “potential,” “projects,” “should,” “could,” “will,” “would” or similar expressions and the negatives of those expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements include, but are not limited to, any statements that refer to projections of our future financial condition and results of operations, capital needs and financing plans, competitive position, industry environment, potential growth and market opportunities, acquisition plans and strategies, compensation plans, governance structure and policies and/or the price of our common stock.

The forward-looking statements included herein represent our management’s current expectations and assumptions based on information available as of the date of this report. These statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) of Part I, and Item 1A (Risk Factors) of Part II, of this Quarterly Report on Form 10-Q/A, and in Item 1 (Business) and Item 1A (Risk Factors) of Part I of our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to place undue reliance on such forward-looking information, which speak only as of the date of this report.

Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time and it is not possible for our management to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual future results to be materially different from those expressed or implied by any forward-looking statements.

Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. We qualify all of our forward-looking statements by these cautionary statements.

1


PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

VERITONE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share and share data)

(Unaudited)

 

 

 

As of

 

 

 

March 31,

 

 

 

 

 

 

 

2022

 

 

December 31,

 

 

 

(As Restated)

 

 

2021

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

237,553

 

 

$

254,722

 

Accounts receivable, net

 

 

66,975

 

 

 

85,063

 

Expenditures billable to clients

 

 

19,693

 

 

 

27,180

 

Prepaid expenses and other current assets

 

 

12,519

 

 

 

12,117

 

Total current assets

 

 

336,740

 

 

 

379,082

 

Property, equipment and improvements, net

 

 

2,137

 

 

 

1,556

 

Intangible assets, net

 

 

91,867

 

 

 

93,872

 

Goodwill

 

 

44,600

 

 

 

42,028

 

Long-term restricted cash

 

 

856

 

 

 

855

 

Other assets

 

 

6,078

 

 

 

954

 

Total assets

 

$

482,278

 

 

$

518,347

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Accounts payable

 

$

38,345

 

 

$

46,711

 

Accrued media payments

 

 

96,327

 

 

 

86,923

 

Client advances

 

 

7,968

 

 

 

10,561

 

Contingent consideration, current

 

 

134

 

 

 

20,053

 

Other accrued liabilities

 

 

22,993

 

 

 

27,093

 

Total current liabilities

 

 

165,767

 

 

 

191,341

 

Convertible senior notes, non-current

 

 

195,381

 

 

 

195,082

 

Contingent consideration, non-current

 

 

35,681

 

 

 

31,533

 

Other non-current liabilities

 

 

17,216

 

 

 

13,891

 

Total liabilities

 

 

414,045

 

 

 

431,847

 

Commitments and contingencies (Note 9)

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Common stock, par value $0.001 per share; 75,000,000 shares authorized; 36,056,839 and 34,972,256 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively

 

 

36

 

 

 

35

 

Additional paid-in capital

 

 

435,954

 

 

 

431,606

 

Accumulated deficit

 

 

(367,843

)

 

 

(345,037

)

Accumulated other comprehensive income (loss)

 

 

86

 

 

 

(104

)

Total stockholders' equity

 

 

68,233

 

 

 

86,500

 

Total liabilities and stockholders' equity

 

$

482,278

 

 

$

518,347

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

(in thousands, except per share and share data)

(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

 

 

 

 

 

(As Restated)

 

 

2021

 

Revenue

 

$

34,407

 

 

$

18,295

 

Operating expenses:

 

 

 

 

 

 

 

 

Cost of revenue

 

 

6,923

 

 

 

4,823

 

Sales and marketing

 

 

11,069

 

 

 

6,427

 

Research and development

 

 

9,883

 

 

 

4,960

 

General and administrative

 

 

22,321

 

 

 

31,543

 

Amortization

 

 

5,016

 

 

 

1,078

 

Total operating expenses

 

 

55,212

 

 

 

48,831

 

Loss from operations

 

 

(20,805

)

 

 

(30,536

)

Other expense, net

 

 

(1,186

)

 

 

(9

)

Loss before provision for income taxes

 

 

(21,991

)

 

 

(30,545

)

Provision for income taxes

 

 

138

 

 

 

22

 

Net loss

 

$

(22,129

)

 

$

(30,567

)

Net loss per share:

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.62

)

 

$

(0.95

)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

Basic and diluted

 

 

35,476,948

 

 

 

32,172,038

 

Comprehensive loss:

 

 

 

 

 

 

 

 

Net loss

 

$

(22,129

)

 

$

(30,567

)

Foreign currency translation gain, net of income taxes

 

 

190

 

 

 

7

 

Total comprehensive loss

 

$

(21,939

)

 

$

(30,560

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share amounts)

(Unaudited)

 

 

 

 

Three Months Ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Deficit

 

 

Comprehensive

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

(As Restated)

 

 

Income

 

 

(As Restated)

 

Balance as of December 31, 2021

 

 

34,972,256

 

 

$

35

 

 

$

431,606

 

 

$

(345,037

)

 

$

(104

)

 

$

86,500

 

Cumulative-effect of accounting change adopted as of January 1, 2022

 

 

 

 

 

 

 

 

 

 

 

(677

)

 

 

 

 

 

(677

)

Common stock issued under employee stock plans

 

 

1,073,543

 

 

 

1

 

 

 

569

 

 

 

 

 

 

 

 

 

570

 

Common stock withheld for employee taxes

 

 

(457,840

)

 

 

 

 

 

(9,437

)

 

 

 

 

 

 

 

 

(9,437

)

Common stock issued for acquisitions

 

 

116,550

 

 

 

 

 

 

1,929

 

 

 

 

 

 

 

 

 

1,929

 

Common stock issued as part of contingent consideration

 

 

352,330

 

 

 

 

 

 

6,440

 

 

 

 

 

 

 

 

 

 

 

6,440

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

4,847

 

 

 

 

 

 

 

 

 

4,847

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(22,129

)

 

 

 

 

 

(22,129

)

Other comprehensive gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

190

 

 

 

190

 

Balance as of March 31, 2022

 

 

36,056,839

 

 

$

36

 

 

$

435,954

 

 

$

(367,843

)

 

$

86

 

 

$

68,233

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Total

 

Balance as of December 31, 2020

 

 

31,799,354

 

 

$

32

 

 

$

368,477

 

 

$

(280,365

)

 

$

66

 

 

$

88,210

 

Common stock issued under employee stock plans, net

 

 

608,886

 

 

 

1

 

 

 

4,253

 

 

 

 

 

 

 

 

 

4,254

 

Common stock issued for services

 

 

15,828

 

 

 

 

 

 

119

 

 

 

 

 

 

 

 

 

119

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

21,491

 

 

 

 

 

 

 

 

 

21,491

 

Exercise of warrants

 

 

252,218

 

 

 

 

 

 

 

2,279

 

 

 

 

 

 

 

 

 

 

 

2,279

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(30,567

)

 

 

 

 

 

(30,567

)

Other comprehensive gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7

 

 

 

7

 

Balance as of March 31, 2021

 

 

32,676,286

 

 

$

33

 

 

$

396,619

 

 

$

(310,932

)

 

$

73

 

 

$

85,793

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

4


 

VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

 

 

 

 

 

(As Restated)

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(22,129

)

 

$

(30,567

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

5,214

 

 

 

1,253

 

Loss on disposal of fixed assets

 

 

 

 

 

1,894

 

Provision for doubtful accounts

 

 

194

 

 

 

5

 

Loss on sublease

 

 

 

 

 

1,211

 

Stock-based compensation expense

 

 

4,847

 

 

 

21,610

 

Change in fair value of contingent consideration

 

 

5,045

 

 

 

 

Change in deferred taxes

 

 

(465

)

 

 

 

Amortization of debt issuance costs

 

 

299

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

18,982

 

 

 

(7,439

)

Expenditures billable to clients

 

 

7,487

 

 

 

2,236

 

Prepaid expenses and other assets

 

 

(18

)

 

 

1,507

 

Other assets

 

 

(895

)

 

 

 

Accounts payable

 

 

(8,384

)

 

 

3,554

 

Accrued media payments

 

 

8,770

 

 

 

9,517

 

Client advances

 

 

(2,593

)

 

 

1,825

 

Other accrued liabilities

 

 

(6,104

)

 

 

(103

)

Other liabilities

 

 

(116

)

 

 

(294

)

Net cash provided by operating activities

 

 

10,134

 

 

 

6,209

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Minority investment

 

 

(2,000

)

 

 

 

Capital expenditures

 

 

(735

)

 

 

(100

)

Acquisitions, net of cash acquired

 

 

(1,319

)

 

 

 

Net cash used in investing activities

 

 

(4,054

)

 

 

(100

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Payment of contingent considerations

 

 

(14,376

)

 

 

 

Taxes paid related to net share settlement of equity awards

 

 

(9,441

)

 

 

 

Proceeds from the exercise of warrants

 

 

 

 

 

2,279

 

Proceeds from issuances of stock under employee stock plans, net

 

 

569

 

 

 

4,254

 

Net cash (used in) provided by financing activities

 

 

(23,248

)

 

 

6,533

 

Net (decrease) increase in cash and cash equivalents and restricted cash

 

 

(17,168

)

 

 

12,642

 

Cash and cash equivalents and restricted cash, beginning of period

 

 

255,577

 

 

 

115,672

 

Cash and cash equivalents and restricted cash, end of period

 

$

238,409

 

 

$

128,314

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

 

 

Non-cash activities:

 

 

 

 

 

 

 

 

Shares issued for acquisition of businesses and earn-out consideration

 

 

8,369

 

 

 

 

Lease liabilities arising from right-of-use assets

 

 

4,501

 

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


VERITONE, INC.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except share and per share data and percentages)

(Unaudited)

NOTE 1. DESCRIPTION OF BUSINESS

Description of Business

Veritone, Inc., a Delaware corporation (“Veritone”) (together with its wholly owned subsidiaries, the “Company”), is a provider of artificial intelligence (“AI”) computing solutions. The Company’s proprietary AI operating system, aiWARETM, uses machine learning algorithms, or AI models, together with a suite of powerful applications, to reveal valuable insights from vast amounts of structured and unstructured data. The aiWARE platform offers capabilities that mimic human cognitive functions such as perception, prediction and problem solving, enabling users to quickly, efficiently and cost effectively transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights.  aiWARE is based on an open architecture that enables new AI models, applications and workflows to be added quickly and efficiently, resulting in a scalable and evolving solution that can be leveraged by organizations across a broad range of business sectors, serving commercial enterprises as well as government and regulated industries.

In addition, the Company operates a full-service advertising agency that leverages the Company’s aiWARE technologies to provide differentiated Managed Services to its clients. The Company’s advertising services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics, specializing in host-endorsed and influencer advertising across primarily radio, podcasting, streaming audio, social media and other digital media channels. The Company’s advertising services also include its VeriAds Network, which is comprised of programs that enable broadcasters, podcasters and social media influencers to generate incremental advertising revenue. The Company also offers cloud-native digital content management solutions and licensing services, primarily to customers in the media and entertainment market. These offerings leverage the Company’s aiWARE technologies, providing customers with unique capabilities to enrich and drive expanded revenue opportunities from their content.

On March 1, 2022, the Company acquired an influencer-based management company, as discussed in more detail in Note 3. On September 14, 2021, the Company acquired PandoLogic, a company incorporated under the laws of the state of Israel, and a leading provider of intelligent hiring solutions, as discussed in more detail in Note 3. PandoLogic’s software platform, PandoIQ, is an AI-enabled talent acquisition and recruitment platform. 

NOTE 2. PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the SEC. Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q/A should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Interim results for the three months ended March 31, 2022 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2022.

The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three month periods presented are unaudited. The December 31, 2021 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.

 

Restatement and Adjustment of Financial Statements

 

Restatement of Previously Issued Financial Statements

On August 9, 2022, the management of the Company and the Audit Committee of the Board of Directors of the Company, after consideration of the relevant facts and circumstances, determined that the Company’s previously issued financial statements as of and for the three months ended March 31, 2022 should be restated, and that such financial statements should no longer be relied upon due to an error related to the calculation of fair value of contingent consideration at the time of the acquisition of PandoLogic, which led to an understatement of goodwill, intangible assets and contingent consideration at the time of the acquisition, an overstatement of subsequent changes to the fair value of contingent consideration, and an understatement of subsequent intangible amortization expense. The restatement results in a non-cash charge that reduces general and administrative expenses and results in a favorable change to net loss for the three months ended March 31, 2022. The Company has restated its financial statements for the three months ended March 31, 2022 for such errors.

 

6


 

Adjustment of Previously Issued Financial Statements

The Company also evaluated the aggregate effects of the errors to its previously issued financial statements in accordance with SEC Staff Accounting Bulletins No. 99 and No. 108 and, based upon quantitative and qualitative factors, determined that the errors were not material to the previously issued financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021 or for any quarterly periods included therein. However, in order to correctly state equity in connection with the filing of this Form 10-Q/A, the December 31, 2021 consolidated balance sheet has been corrected to reflect the impact of this immaterial error.  The Company will adjust its consolidated financial statements for the year ended December 31, 2021 when it files its Form 10-K for the period ended December 31, 2022.

The following tables present the effects of the aforementioned restatement to the specific line items presented in the Company’s previously reported unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 (in thousands, except per share amounts):

 

Condensed Consolidated Balance Sheet

 

 

 

As of March 31, 2022

 

 

 

As Reported

 

 

Adjustment

 

 

As Restated

 

Intangible assets, net

 

$

86,563

 

 

$

5,304

 

 

$

91,867

 

Goodwill

 

 

36,630

 

 

 

7,970

 

 

 

44,600

 

Total assets

 

 

469,004

 

 

 

13,274

 

 

 

482,278

 

Contingent consideration, non-current

 

 

35,416

 

 

 

265

 

 

 

35,681

 

Other non-current liabilities

 

 

16,440

 

 

 

776

 

 

 

17,216

 

Total liabilities

 

 

413,004

 

 

 

1,041

 

 

 

414,045

 

Accumulated deficit

 

 

(380,076

)

 

 

12,233

 

 

 

(367,843

)

Total stockholders' equity

 

 

56,000

 

 

 

12,233

 

 

 

68,233

 

Total liabilities and stockholders' equity

 

 

469,004

 

 

 

13,274

 

 

 

482,278

 

 

Condensed Consolidated Statement of Operations and Comprehensive Loss

 

 

 

Three Months Ended

 

 

 

March 31, 2022

 

 

 

As Reported

 

 

Adjustment

 

 

As Restated

 

General and administrative

 

$

28,917

 

 

$

(6,596

)

 

$

22,321

 

Amortization

 

 

4,693

 

 

 

323

 

 

 

5,016

 

Total operating expenses

 

 

61,485

 

 

 

(6,273

)

 

 

55,212

 

Loss from operations

 

 

(27,078

)

 

 

6,273

 

 

 

(20,805

)

Loss before provision for income taxes

 

 

(28,264

)

 

 

6,273

 

 

 

(21,991

)

Provision for income taxes

 

 

177

 

 

 

(39

)

 

 

138

 

Net loss

 

 

(28,441

)

 

 

6,312

 

 

 

(22,129

)

Basic and diluted net loss per share